Remus Pharmaceuticals Limited - Laporan Arus Kas (TTM)

Remus Pharmaceuticals Limited
IN ˙ NSEI
Laporan Arus Kas (TTM)

Laporan Arus Kas Remus Pharmaceuticals Limited menunjukkan perubahan posisi kas dari waktu ke waktu. Data Laporan Arus Kas meliputi Kas dari Aktivitas Operasional (CFOP), Kas dari Aktivitas Investasi, dan Kas dari Aktivitas Pendanaan.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2021
03-31
2022
03-31
2023
03-31
2024
03-31
2025
03-31
Cash From Operating Activities 28 50 53 36 70
Change (%) 77.52 5.46 -32.20 93.76
% of Cash Flow -772.01 1,583.75 281.17 18.93 279.20
Cash From Investing Activities -31 -45 -152 -89 -106
Change (%) 47.09 234.23 -41.14 17.98
% of Cash Flow 840.64 -1,428.92 -803.97 -47.00 -422.00
Cash From Financing Activities -1 -2 118 244 61
Change (%) 51.13 -6,847.99 107.04 -75.09
% of Cash Flow 31.39 -54.83 622.80 128.07 242.80
Cash Flow -4 3 19 190 25
Change (%) -186.53 494.03 906.87 -86.86
% of Cash Flow 100.00 100.00 100.00 100.00 100.00

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista